ロード中...
Future Challenges in Cancer Resistance to Immunotherapy
Cancer immunotherapies, including checkpoint inhibitors, adoptive T cell transfer and therapeutic cancer vaccines, have shown promising response rates in clinical trials. Unfortunately, there is an increasing number of patients in which initially regressing tumors start to regrow due to an immunothe...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226490/ https://ncbi.nlm.nih.gov/pubmed/32290124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040935 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|